and R.A.H.-L
(PubMed) Bermudez Y, Benavente CA, Meyer RG, Coyle WR, Jacobson MK, Jacobson EL
For T0901317 experiments, mice were injected intraperitoneally with either vehicle (10%DMSO in 90% corn oil) or T0901317 (MedChem Express, HY-10626) at a dose of either 16.9 mg/kg or 50 mg/kg dose for either 4 days (1720) days post AAV-TBG-Cre treatment) or 14 days (720) days post AAV-TBG-Cre treatment)
GLP-1 alleviates hepatocyte steatosis and reduces intracellular lipid droplets by activating the expression of the above lipid metabolism genes
Parametric variables were analyzed employing paired and unpaired t tests to compare means within groups and between groups, respectively
Current evidence from large cardiovascular outcome trials provides reassurance that this modest chronotropic effect does not translate into increased cardiovascular risk for most patients